Debunking Five Misconceptions About Community-Based Research Sites In Clinical Trials
By Miranda McLaren

Explore the transformative potential of community-based research sites in clinical trials, particularly in enhancing patient experiences and fostering diversity. Traditional trial models often struggle to recruit minority populations due to logistical barriers, but community-based approaches significantly improve accessibility and engagement. EmVenio Research, a PCM Trials company, exemplifies this shift by reporting that over 50% of its participants come from minority backgrounds, coupled with a remarkable 92% retention rate.
by confronting common misconceptions about community-based research, such as recruitment challenges and regulatory compliance, this article demonstrates that these sites can effectively manage complex trials while maintaining high standards of care. By embedding research within local healthcare infrastructures, trust and credibility are fostered, making trials more appealing to diverse communities. Although initial costs may be higher due to the establishment of decentralized centers, the long-term benefits include enhanced patient retention and reduced dropout rates, ultimately leading to cost savings and more representative clinical research. EmVenio's centralized project management approach not only enhances the inclusivity and efficiency of clinical trials but also contributes to better treatment outcomes, positioning community-based research as a vital component of future clinical investigations.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.